Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 145
Item hits:
Issue DateTitleAuthor(s)
6-Sep-2016Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysisRamaswami, R; Pinato, DJ; Kubota, K; Ishizuka, M; Arizumi, T, et al
29-Mar-2016p53 loss in MYC-driven neuroblastoma leads to metabolic adaptations supporting radioresistanceYogev, O; Barker, K; Sikka, A; Almeida, GS; Hallsworth, A, et al
29-Apr-2016“Watching the Detectives” report of the general assembly of the EU project DETECTIVE Brussels, 24-25 November 2015Fernando, RN; Chaudhari, U; Escher, SE; Hengstler, JG; Hescheler, J, et al
29-Feb-2016Positron emission tomography imaging of tumor cell metabolism and application to therapy response monitoringAboagye, EO; Challapalli, A
4-Oct-2016The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancerAntony, J; Tan, TZ; Kelly, Z; Low, J; Choolani, M, et al
8-Nov-2016Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signalingRutherford, C; Speirs, C; Williams, JJL; Ewart, MA; Mancini, SJ, et al
6-Nov-2016Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancerAlifrangis, C; Thornton, A; Fotopoulou, C; Krell, J; Gabra, H
12-Apr-2016Gene of the month: HGFJiao, LR; Fajardo, A; Frampton, A; Imperial College Healthcare NHS Trust- BRC Funding; Imperial College Healthcare NHS Trust- BRC Funding
16-Aug-2016CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous CarcinomaWalton, J; Blagih, J; Ennis, D; Leung, E; Dowson, S, et al
29-Jun-2016Prognostic pathways in early-stage ovarian cancer: can gene expression transcend histological subtype?McNeish, IA